{"id":"e0c8ff86-202c-5639-8c90-3833c3fd7583","stable_key":"8b3cf083-ea9c-54f5-b42b-bf1fef5b2978:metformin-mate1-variant-response","predicate":"modulates","statement":"The SLC47A1 rs2289669 A allele was associated with a 0.30% larger HbA1c reduction per allele during metformin treatment.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"caec7865-f667-51f2-ba24-3733f25a6fc2","mechanism_event_label":"How quickly the body clears the drug tracks with how much it lowers long-term glucose.","subject":{"id":"198b7bfb-7e85-5c91-94b7-32603452a8e3","slug":"slc47a1","display_name":"Human multidrug and toxin extrusion protein 1 / MATE1 / SLC47A1","entity_type_key":"protein"},"object":{"id":"5deaa98d-e81e-521d-b810-a9228333e4ca","slug":"glycated-hemoglobin-concentration","display_name":"Glycated hemoglobin / HbA1c concentration","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"caec7865-f667-51f2-ba24-3733f25a6fc2","stable_key":"8b3cf083-ea9c-54f5-b42b-bf1fef5b2978:metformin-mate1-variant-response-event","event_type":"observed_intervention","label":"How quickly the body clears the drug tracks with how much it lowers long-term glucose.","description":"The SLC47A1 rs2289669 A allele was associated with a 0.30% larger HbA1c reduction per allele during metformin treatment.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"519971b1-5aef-5ad7-8022-840144855cd0","slug":"metformin","display_name":"Metformin","entity_type_key":"drug"},"role":"administered_drug","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"198b7bfb-7e85-5c91-94b7-32603452a8e3","slug":"slc47a1","display_name":"Human multidrug and toxin extrusion protein 1 / MATE1 / SLC47A1","entity_type_key":"protein"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"5deaa98d-e81e-521d-b810-a9228333e4ca","slug":"glycated-hemoglobin-concentration","display_name":"Glycated hemoglobin / HbA1c concentration","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/metformin-research/19228809.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"e90099f316586ff994eff67af58f075f654413a68d8605e869755e9b8c68adb3\", \"start_char\": 0, \"end_char\": 1383, \"text_sha256\": \"e90099f316586ff994eff67af58f075f654413a68d8605e869755e9b8c68adb3\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Pharmacogenetic analysis of 116 incident metformin users in the Rotterdam Study","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Twelve tagging SNPs in SLC47A1 against change in HbA1c","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"A preliminary association in a small sample that the authors say requires replication; no mechanism was measured.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake.","comparator":null,"unit":null,"notes":"","entity":{"slug":"metformin","display_name":"Metformin","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Human","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"How quickly the body clears the drug tracks with how much it lowers long-term glucose.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[metformin-p19228809] Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study. (2009). https://pubmed.ncbi.nlm.nih.gov/19228809/ DOI: 10.2337/db08-1028","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Glycaemic response","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"6d5116b2-49e7-5dee-adec-8e9864ec297d","evidence_kind":"source_excerpt","locator":"Lines 372-383","start_line":372,"end_line":383,"excerpt":"### metformin-mate1-variant-response\nThe SLC47A1 rs2289669 A allele was associated with a 0.30% larger HbA1c reduction per allele during metformin treatment.\nCondition category: normal\nnutrient_topic: Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake.\nplain_language: How quickly the body clears the drug tracks with how much it lowers long-term glucose.\norganism: Human\ntissue_or_cell_type: Glycaemic response\nexperimental_model: Pharmacogenetic analysis of 116 incident metformin users in the Rotterdam Study\nlimitations: A preliminary association in a small sample that the authors say requires replication; no mechanism was measured.\nexposure: Twelve tagging SNPs in SLC47A1 against change in HbA1c\nevidence_span: {\"source_cache\": \"artifacts/metformin-research/19228809.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"e90099f316586ff994eff67af58f075f654413a68d8605e869755e9b8c68adb3\", \"start_char\": 0, \"end_char\": 1383, \"text_sha256\": \"e90099f316586ff994eff67af58f075f654413a68d8605e869755e9b8c68adb3\"}\n[metformin-p19228809] Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study. (2009). https://pubmed.ncbi.nlm.nih.gov/19228809/ DOI: 10.2337/db08-1028","model_system":"Pharmacogenetic analysis of 116 incident metformin users in the Rotterdam Study","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [metformin-p19228809] Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study. (2009). https://pubmed.ncbi.nlm.nih.gov/19228809/ DOI: 10.2337/db08-1028","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"d0474bd9-7cfd-5695-a152-12f3633a6813","stable_key":"import-8b3cf083-ea9c-54f5-b42b-bf1fef5b2978","title":"Metformin: transport, molecular targets, gut mechanisms and nutrient interactions (2026-09-19)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"0b51d0759aeeb88ac5b3a6277245a196b2bb024d7c32ec89379ed428fb06bfb5","revision_id":"0405c75e-f06e-5af7-a642-1777802f6004","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}